Moderna is navigating a post-COVID transition, shifting focus to a diversified vaccine and therapeutics pipeline amid weak demand. Read more on MRNA stock here.
The version 7.0 update for Genshin Impact, dubbed “Everwinter Without Mercy,” will launch on August 12, developer miHoYo announced.
I maintain my Strong Buy rating Lam Research (LRCX) with a revised price target of $455 per share. LRCX’s Q4 2026 results exceeded expectations, supporting an increased FWD non-GAAP EPS estimate to $9 ...
Here's a 100% collectible guide for locations of all treasure chests and secrets buried in the Antocha Wreck in Assassin's ...
Major stock indexes pulled back sharply ahead of the Federal Reserve’s decision on interest rates and Big Tech earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results